Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction

ABSTRACT: Background: Dengue is an important public health problem worldwide. A vaccine has recently been licensed in some countries of Latin America and Asia. Recommendations for dengue vaccine introduction include endemicity and a high serological prevalence of dengue in the territories considerin...

Full description

Autores:
Carabali, Mabel
Kyungah Lima, Jacqueline
Vélez, Diana Carolina
Trujillo Correa, Andrea Isabel
Egurrola Pedraza, Jorge Armando
Sung Lee, Kang
Kaufman, Jay S.
DaSilva, Luiz Jacinto
Vélez Bernal, Iván Darío
Osorio Benítez, Jorge Emilio
Tipo de recurso:
Article of investigation
Fecha de publicación:
2017
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/27884
Acceso en línea:
http://hdl.handle.net/10495/27884
Palabra clave:
Dengue
Prevalence
Prevalencia
Seroconversion
Viral Load
Carga Viral
Child
Niño
Adult
Adulto
Colombia
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_fa98e7275995044748b36aa0c4b1421f
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/27884
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
title Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
spellingShingle Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
Dengue
Prevalence
Prevalencia
Seroconversion
Viral Load
Carga Viral
Child
Niño
Adult
Adulto
Colombia
title_short Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
title_full Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
title_fullStr Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
title_full_unstemmed Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
title_sort Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introduction
dc.creator.fl_str_mv Carabali, Mabel
Kyungah Lima, Jacqueline
Vélez, Diana Carolina
Trujillo Correa, Andrea Isabel
Egurrola Pedraza, Jorge Armando
Sung Lee, Kang
Kaufman, Jay S.
DaSilva, Luiz Jacinto
Vélez Bernal, Iván Darío
Osorio Benítez, Jorge Emilio
dc.contributor.author.none.fl_str_mv Carabali, Mabel
Kyungah Lima, Jacqueline
Vélez, Diana Carolina
Trujillo Correa, Andrea Isabel
Egurrola Pedraza, Jorge Armando
Sung Lee, Kang
Kaufman, Jay S.
DaSilva, Luiz Jacinto
Vélez Bernal, Iván Darío
Osorio Benítez, Jorge Emilio
dc.subject.decs.none.fl_str_mv Dengue
Prevalence
Prevalencia
Seroconversion
Viral Load
Carga Viral
Child
Niño
Adult
Adulto
topic Dengue
Prevalence
Prevalencia
Seroconversion
Viral Load
Carga Viral
Child
Niño
Adult
Adulto
Colombia
dc.subject.proposal.spa.fl_str_mv Colombia
description ABSTRACT: Background: Dengue is an important public health problem worldwide. A vaccine has recently been licensed in some countries of Latin America and Asia. Recommendations for dengue vaccine introduction include endemicity and a high serological prevalence of dengue in the territories considering its introduction. Methods: A community-based survey was conducted to estimate dengue seroprevalence and age-specific seroconversion rates in a community in Medellin, Colombia, using a dengue serological test (IgG indirect ELISA). Residents were selected at random and were first screened for dengue infection; they were then followed over 2.5 years. Results: A total of 3684 individuals aged between 1 and 65 years participated in at least one survey. The overall dengue seroprevalence was 61%, and only 3.3% of seropositive subjects self-reported a past history of dengue. Among dengue virus (DENV)-naïve subjects with more than two visits (n=1002), the overall seroconversion rate was 8.7% (95% confidence interval 7.3-10.4) per 1000 person-months, over the study period. Overall, the mean age of DENV prevalent subjects was significantly higher than the mean age of seroconverted subjects. Specifically, DENV seropositivity over 70% was observed in participants over 21 years old. Serotype-specific plaque-reduction neutralization tests (PRNT) revealed that all four dengue serotypes were circulating, with DENV4 being most prevalent. Conclusions: These laboratory-based findings could inform dengue vaccine decisions, as they provide age-specific seroprevalence and seroconversion data, evidencing permanent and ongoing dengue transmission in the study area. This study provides evidence for the existing rates of secondary and heterotypic responses, presenting a challenge that must be addressed adequately by the new vaccine candidates
publishDate 2017
dc.date.issued.none.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2022-04-26T20:26:25Z
dc.date.available.none.fl_str_mv 2022-04-26T20:26:25Z
dc.type.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.hasversion.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ART
dc.type.local.spa.fl_str_mv Artículo de investigación
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.issn.none.fl_str_mv 1201-9712
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10495/27884
dc.identifier.doi.none.fl_str_mv 10.1016/j.ijid.2017.02.016
identifier_str_mv 1201-9712
10.1016/j.ijid.2017.02.016
url http://hdl.handle.net/10495/27884
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Int. J. Infect. Dis.
dc.rights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.accessrights.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
http://purl.org/coar/access_right/c_abf2
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.format.extent.spa.fl_str_mv 10
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Elsevier ; International Society for Infectious Diseases
dc.publisher.group.spa.fl_str_mv Programa de Estudio y Control de Enfermedades Tropicales (PECET)
dc.publisher.place.spa.fl_str_mv Hamilton, Canadá
institution Universidad de Antioquia
bitstream.url.fl_str_mv http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/2/license_rdf
http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/3/license.txt
http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/1/VelezIvan_2017_DengueSerologicalSurvey.pdf
bitstream.checksum.fl_str_mv b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
d51f55363914d4871589420b989066d0
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Antioquia
repository.mail.fl_str_mv andres.perez@udea.edu.co
_version_ 1812173074974375936
spelling Carabali, MabelKyungah Lima, JacquelineVélez, Diana CarolinaTrujillo Correa, Andrea IsabelEgurrola Pedraza, Jorge ArmandoSung Lee, KangKaufman, Jay S.DaSilva, Luiz JacintoVélez Bernal, Iván DaríoOsorio Benítez, Jorge Emilio2022-04-26T20:26:25Z2022-04-26T20:26:25Z20171201-9712http://hdl.handle.net/10495/2788410.1016/j.ijid.2017.02.016ABSTRACT: Background: Dengue is an important public health problem worldwide. A vaccine has recently been licensed in some countries of Latin America and Asia. Recommendations for dengue vaccine introduction include endemicity and a high serological prevalence of dengue in the territories considering its introduction. Methods: A community-based survey was conducted to estimate dengue seroprevalence and age-specific seroconversion rates in a community in Medellin, Colombia, using a dengue serological test (IgG indirect ELISA). Residents were selected at random and were first screened for dengue infection; they were then followed over 2.5 years. Results: A total of 3684 individuals aged between 1 and 65 years participated in at least one survey. The overall dengue seroprevalence was 61%, and only 3.3% of seropositive subjects self-reported a past history of dengue. Among dengue virus (DENV)-naïve subjects with more than two visits (n=1002), the overall seroconversion rate was 8.7% (95% confidence interval 7.3-10.4) per 1000 person-months, over the study period. Overall, the mean age of DENV prevalent subjects was significantly higher than the mean age of seroconverted subjects. Specifically, DENV seropositivity over 70% was observed in participants over 21 years old. Serotype-specific plaque-reduction neutralization tests (PRNT) revealed that all four dengue serotypes were circulating, with DENV4 being most prevalent. Conclusions: These laboratory-based findings could inform dengue vaccine decisions, as they provide age-specific seroprevalence and seroconversion data, evidencing permanent and ongoing dengue transmission in the study area. This study provides evidence for the existing rates of secondary and heterotypic responses, presenting a challenge that must be addressed adequately by the new vaccine candidates001509910application/pdfengElsevier ; International Society for Infectious DiseasesPrograma de Estudio y Control de Enfermedades Tropicales (PECET)Hamilton, Canadáinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTArtículo de investigaciónhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/http://purl.org/coar/access_right/c_abf2https://creativecommons.org/licenses/by-nc-nd/4.0/Dengue virus serological prevalence and seroconversion rates in children and adults in Medellin, Colombia : implications for vaccine introductionDenguePrevalencePrevalenciaSeroconversionViral LoadCarga ViralChildNiñoAdultAdultoColombiaInt. J. Infect. Dis.International Journal of Infectious Diseases273658CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/2/license_rdfb88b088d9957e670ce3b3fbe2eedbc13MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/3/license.txt8a4605be74aa9ea9d79846c1fba20a33MD53ORIGINALVelezIvan_2017_DengueSerologicalSurvey.pdfVelezIvan_2017_DengueSerologicalSurvey.pdfArtículo de investigaciónapplication/pdf1993651http://bibliotecadigital.udea.edu.co/bitstream/10495/27884/1/VelezIvan_2017_DengueSerologicalSurvey.pdfd51f55363914d4871589420b989066d0MD5110495/27884oai:bibliotecadigital.udea.edu.co:10495/278842022-05-09 11:46:40.185Repositorio Institucional Universidad de Antioquiaandres.perez@udea.edu.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